Latest filing published 16 Sept 2026 for Medtronic plc, €120k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Kiil Harry Skip discloses dealings in Medtronic plc to SEC (Form 4). In total, 2 filings cover trades dated from 8 June 2026 to 16 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 16 September 2026, reports a transaction of €120k in Medtronic plc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations